| Literature DB >> 33963604 |
Shin-Ichi Ansai1, Yoshihiro Umebayashi2, Noriyuki Katsumata3, Hiroshi Kato4, Takafumi Kadono5, Toshihiro Takai6, Takeshi Namiki7, Masahiro Nakagawa8, Toshinori Soejima9, Hiroshi Koga10, Makoto Sugaya11.
Abstract
In consideration of the development of treatment options for squamous cell carcinoma (SCC), the Japanese Skin Cancer Society issued the first guidelines of SCC in 2007 and revised them in 2015. Here, we report the English version of the 2020 edition of the Japanese SCC guidelines. The first half of this article is an overview of SCC including actinic keratosis and Bowen's disease, and the second half discusses three clinical questions: (i) treatment of actinic keratosis; (ii) determination of the resection margin of the primary lesion; and (iii) treatment of radically incurable cases, as contemporary problems encountered in treating SCC. In these evaluations, all processes were implemented according to the Grading of Recommendations, Assessment, Development, Evaluation system. Also, items of recommendation concerning each clinical question were determined by a multidisciplinary expert panel consisting of dermatologists, plastic/reconstructive surgeons, radiologists, and oncologists through a comprehensive literature search and systematic reviews.Entities:
Keywords: actinic keratosis; bowen disease; guidline; solar keratosis; squamous cell carcinoma
Mesh:
Year: 2021 PMID: 33963604 DOI: 10.1111/1346-8138.15889
Source DB: PubMed Journal: J Dermatol ISSN: 0385-2407 Impact factor: 4.005